feed,title,long_url,short_url
Benzinga,AbbVie - Roche's Venclexta Receives Breakthrough Therapy Tag In High-Risk Myelodysplastic Syndromes,https://benzinga.com/general/biotech/21/07/22077335/abbvie-roches-venclexta-receives-breakthrough-therapy-tag-in-high-risk-myelodysplastic-syndromes,https://j.mp/3xWPfmP
